Biopharmaceutical manufacturer creating 100 jobs to accommodate growth
COLUMBIA, S.C. – AmbioPharm, Inc. (API), a full-service peptide and biopharmaceutical manufacturing company, is expanding its existing Aiken County operations. The expansion is projected to bring $18 million of new capital investment and lead to the creation of 100 jobs over the next five years.
AmbioPharm started its business in South Carolina in 2007 by establishing its company headquarters and downstream manufacturing operations in a 10,000-square-foot facility in the North Augusta Industrial Park. That same year, API also opened its Shanghai, China operations, which focuses on the synthesis, as well as the research and development, of pharmaceutical products. In 2014 and 2015, the company made major facility expansions to its Aiken County operations.
Located at 1024 Dittman Court in North Augusta, S.C., AmbioPharm will be constructing two additional freestanding buildings, totaling 50,000 square feet, and purchasing additional equipment. Hiring for the new positions is projected to begin in the second quarter of 2018, and interested applicants should visit www.ambiopharm.com for more information.
The Coordinating Council for Economic Development has approved job development credits related to this project.
“AmbioPharm continues to be grateful for the support that it receives from the state of South Carolina. Without this support, our business could not grow at the accelerated pace that our customers have come to expect.” –AmbioPharm, Inc. CFO Stephen Kiel
“Today, we’re proud to celebrate AmbioPharm, Inc.’s continued success and growth in Aiken County. In South Carolina, our workforce has proven that it’s one of the best in the world, and the expansion of this innovative biopharmaceutical operation is a testament to that.” –Gov. Henry McMaster
“South Carolina’s advanced manufacturing industry has put our state on the map, and AmbioPharm’s latest expansion is a testament to that. By growing its already significant operations in our state, AmbioPharm is making a statement that South Carolina, with our pro-business environment and highly-skilled workforce, is ‘Just right’ for business.” –Secretary of Commerce Bobby Hitt
“An expansion by one of our existing industries is a reason to celebrate, and we want to thank AmbioPharm for this great news! Aiken County is a better place because of companies like AmbioPharm. Aiken County Council appreciates the partnership we have with this company and will continue to work closely with them to foster even more growth.” –Aiken County Council Chairman Andrew Siders
“AmbioPharm’s continued growth and expansion are impressive. I’m glad it calls North Augusta home. AmbioPharm is our city’s best kept secret. People will better appreciate it as they become more acquainted with this great company.” –North Augusta Mayor Bob Pettit
“We want to thank AmbioPharm for today’s expansion announcement. Their continued growth is important to all the citizens of Aiken County, and the products they produce are important to the health and well-being of the country.” –Economic Development Partnership Chairman Gary Stooksbury
FIVE FAST FACTS
- AmbioPharm, Inc. expanding existing Aiken County operations.
- $18 million investment to create 100 new jobs over the next five years.
- AmbioPharm is one of the leading full-service peptide and biopharmaceutical manufacturers in the world.
- Located at 1024 Dittman Court in North Augusta, S.C., the company will be constructing two additional buildings and purchasing new equipment.
- Hiring for the new positions should begin in the second quarter of 2018, and interested applicants should visit www.ambiopharm.com for more information.